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ABSTRACT: The data emerging out of the clinical trial indicated significant clinical relief and 
favourable shift of grades of the clinical components of anxiety namely nervousness, palpitation, 
insomnia, irritability, lack of concentration etc.  Following Medhya Rasayana therapy.  The 
elements of underlying depression as measured by a depression scale were also found reduced.  
The patients reported an increasing feeling of well being and showed a tendency of gain in body 
weight besides corrections of pulse rate and blood pressure. 
Introduction: 
Caraka has described four Classical Medhya 
Rasayana drugs in Cikitsa Sthana chapter 1 
namely Sankhapuspi Mandukaparni, Guduci 
and Yastimadhu.  The Medhya Rasayanas in 
general are considered as brain tonics 
besides their anti-anxiety activity as reported 
by Singh and associates (1977).  The Four 
Medhya Rasayanas of Caraka Samhita have 
been studied individually by Sinha (1981) 
clinically as well as experimentally.  The 
present study intends to undertake a clinical 
evaluation of the combined use of all the 
Four Medhya Rasayanas. Sinha (1981) 
reported that when evaluated individually 
only two of the Four Medhya Rasayana 
drugs namely Sankhapuspi and 
Mandukapatni act as significant anti-anxiety 
agents.  The remaining two drugs namely 
Amrta and Yastimadhu did not show 
significant antianxiety  effect on 
psychological parameters, However, it was 
postulated that these latter two drugs may 
have adjuvant effects of some unknown kind 
in Medhya Rasayana therapy.  Therefore we 
thought to combine all the Four Medhya 
Rasayana drugs and use them in the form of 
a compound in the treatment of anxiety 
neurosis to assess the efficacy of the 
compound Medhya Rasayana as an anti-
anxiety drug. 
Materials and Methods 
A series of 28 cases of Anxiety Neurosis 
were selected from Kayachikitsa outpatient 
department, S.S. Hospital, B.H.U. The 
patients were registered for the present study 
with the help of a proforma prepared for the 
purpose. Each case was interviewed 
individually and his basal condition was 
assessed on following parameters. 
1.  General Clinical Presentation: The 
form of clinical presentation and the 
psycho-social background was 
worked out in each case. Page 11-16 
2.  Clinical Anxiety Scale- was applied 
to measure the degree of clinical 
anxiety syndrome in terms of major 
symptoms produced by anxiety such 
as nervousness, palpitation insomnia, 
lack of concentration, irritability, 
headache, tremors anorexia and 
certain other features of 
gastrointestinal neurosis.  The scale 
applied for the purpose gives a semi-
objective measurement of the 
severity of the symptoms (Table 1). 
TABLE –I 
Clinical Anxiety Scale 
S.
N
o 
Symptoms  Grading  Sc
ore
s 
1.  Nervousness  Always 
Often 
At occasions 
Never 
-3 
-2 
-1 
-0 
2  Palpitation  Always 
Often 
At occasions 
Never 
-3 
-2 
-1 
-0 
3  Tremors  Marked 
Fine 
Minor 
No 
-3 
-2 
-1 
-0 
4  Headache  Always 
Often 
Sometimes 
No 
-3 
-2 
-1 
-0 
5  Anorexia  Marked 
Minor  
Very minor 
No 
-3 
-2 
-1 
-0 
6  Insomnia  Insomnia 
Poor sleep 
Disturbed sleep 
No 
-3 
-2 
-1 
-0 
7  Lack of 
concentration 
Troublesome 
Marked 
Minor 
No 
-3 
-2 
-1 
-0 
8  Dyspepsia/Fl
atulence 
Troublesome 
Marked 
-3 
-2 
Minor 
No 
-1 
-0 
9  Fatigue/Exha
ustion 
Always 
Towards the 
evening 
-3 
 
-2 
10  Irritability  Always 
Often 
Sometimes 
No 
-3 
-2 
-1 
-0 
 
3.  A mini Depression Scale was applied 
in each case in the form of a limited 
questionnaire which measures the 
degree of depression.  Though we 
selected cases who had no obvious 
depression, on measurement with 
this scale all cases showed some 
degree of depression. 
 
4.  Psychotic Symptom Scale – Besides 
measuring the level of clinical 
anxiety and the degree of depression 
we subjected each case to a simple 
psychosis symptoms scale in order to 
work out the presence or absence of 
psychotic manifestations in thee 
cases. It may be pointed out that we 
excluded all such patients from our 
trial series where psychotic 
manifestation were encountered thus 
this scale was used for the purpose of 
exclusion (Table 2). 
 
5.  Phychological and Biochemical 
Studies: Each of this patients was 
evaluated for his physiological status 
in terms of B.P. pulse and body 
weight.  Wherever possible we 
subjected these patients to 
biochemical investigations relevant 
to mental health. 
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After basal assessment of each case on 
above parameters the patients were 
subjected to the following schedule of 
therapy the efficacy of which was assessed 
on the following parameters  
Each patient selected for the trial was 
prescribed Medhya Rasayana Kasaya in the 
dose of 50gm in two divided doses 50gm 
crude dry drug was boiled with 800 ml water 
reduced to 100ml administered in two 
divided doses.  The same treatment was 
continued for 6 weeks and the patients were 
reassessed every fortnight for the effect of 
treatment given on the following parameters 
adapting a self control system. 
1.  – Clinical Recovery 
2.  –Change in Clinical anxiety Scale 
3.  –changes in Depression Scale 
4.  – Physiological and Biochemical  
   changes 
5.  – General Health Improvement 
TABLE –II 
Psychosis Symptom Scale 
 
1. 
 
Excitement  
-  Negligible 
-  Excited speech 
-  Excited motor 
-  Activity 
-  violence 
 
-0  ( )  ( )  ( ) 
-1  ( )  ( )  ( ) 
-2  ( )  ( )  ( ) 
 
-3  ( )  ( )  ( ) 
2.   Disorientation 
-No 
-Minor 
-Moderate 
-Severe 
 
 
-0  ( )  ( )  ( ) 
-1  ( )  ( )  ( ) 
-2  ( )  ( )  ( ) 
-3  ( )  ( )  ( ) 
3.  Perceptual disorder 
including hallucination 
and delusion 
-No 
- Sometimes 
-Often 
-Always 
 
 
 
-0  ( )  ( )  ( ) 
-1  ( )  ( )  ( ) 
-2  ( )  ( )  ( ) 
-3  ( )  ( )  ( ) 
4.  Motor disturbances 
-No 
-Incoherence talk 
-Stereotype 
-Irrelevant talk 
 
-0  ( )  ( )  ( ) 
-1  ( )  ( )  ( ) 
-2  ( )  ( )  ( ) 
-3  ( )  ( )  ( ) 
5.  Disorders of thought and 
conceptual disorganization 
-No 
-Incoherence talk 
-Stereotype 
-Irrelevant talk 
 
 
 
-0  ( )  ( )  ( ) 
-1  ( )  ( )  ( ) 
-2  ( )  ( )  ( ) 
-3  ( )  ( )  ( ) 
6.  Depression and Apathy 
-No 
- General disinterest 
-Reduced motor activity 
Guilt and suicidal ideas 
- Refuses to eat and drink 
-No care for urination and 
defaecation 
 
-0  ( )  ( )  ( ) 
-1  ( )  ( )  ( ) 
-2  ( )  ( )  ( ) 
-3  ( )  ( )  ( ) 
-3  ( )  ( )  ( ) 
 
-3  ( )  ( )  ( ) 
 
Results and Observations 
1.  Clinical Anxiety Scale  –  the 
subjective relief in these patients was 
recorded by  quantitatively grading 
the major symptoms present in these 
patients such as nervousness, 
palpitation, insomnia, fatigue, 
dyspepsia, anorexia, lack of 
concentration, headache and 
irritability.  Most of these symptoms 
were found quantitatively decreased 
after one month of treatment worth 
the trial drug.  The grade scores of 
nervousness and headache showed 
maximum improvement (p<0.001) 
while lack of concentration and 
irritability showed moderate 
recovery (P<0.05) after 6 weeks of 
treatment (Table 3, 4). 
 
2.  Clinical Depression Scale  –  The 
effect of the treatment was also 
assessed in terms of the degree of 
depression.  As can be seen from the Page 11-16 
table the depression Index was found 
significantly reduced (p<0.01) after 
the course of therapy (Table5). 
 
3.  Physiological Studies – The follow 
up studies showed a trend increase in 
body weight in patients receiving 
Medhya Rasayana for one month.  
The average pulse rate of these 
patients was found significantly 
(p<0.05) reduce.  The blood pressure 
was also found slightly lowered.  
Thus there is a definite physiological 
rectification and biological 
improvement in persons receiving 
Medhya Rasayana therapy. 
 
4.  General Health Improvement  – 
The patients reported a growing 
feeling of wellbeing and 
improvement in general health with 
increase in body weight during the 
course of Medhya Rasayana therapy.  
Such a feeling of wellbeing appears 
to be a secondary attribute to the 
anti-anxiety and adaptogenic effect 
of the trial drug besides its general 
restorative effects. 
Discussion 
As stated at the outset, the present 
investigation aims to undertake a clinical 
evaluation of the combined Medhya 
Rasayana therapy in Manas Roga.  As 
anxiety forms the major component of 
almost all Manas Rogas, in the present 
context we  
 
TABLE – III 
Showing the pattern of reduction in clinical anxiety as observed during 1
st follow up of 28 
cases of anxiety neurosis after 2 weeks of treatment with Medhya Rasayana 
S. 
No 
Symptoms  Initials  Follow up  t  p 
Mean ± S.D.  Mean ± S.D. 
1  Nervousness  2.35 ± 0.271  1.88 ± 0.598  3.79        0.001 
2  Palpitation  2.10 ± 0.631  1.46 ± 0.786  3.38        0.001 
3  Tremors  1.35 ± 0.925  6.00 ± 0.811  2.90        0.01 
4  Headache  1.92 ±0.774  1.17 ± 0.816  3.63        0.001 
5  Anorexia  1.92 ± 0.819  1.35 ± 0.498  3.16        0.01 
6  Insomnia  1.71 ± 1.037  1.07 ± 1.060  2.17        0.01 
7  Lack of 
concentration 
2.14 ± 0.18   1.53 ± 1.020  2.46        0.02 
8  Dyspepsia / 
Flatulence 
2.14 ± 0.675  1.35 ± 0.905  3.70        0.001 
 
9  Fatigue / 
Exhaustion  
2.60 ± 1.073  1.46 ± 0.912  4.26        0.001 
 
10  Irritability  2.28 ± 1.020  1.64 ± 0.859  2.41        0.02 
 
Values are Mean Grade Scores ± S.D. Difference compared wit respective initial values Page 11-16 
TABLE – IV 
Showing the pattern of reduction in clinical anxiety as observed during II
nd  follow up of 12 
cases of anxiety neurosis after 1 month of treatment with Medhya Rasayana 
S. 
No 
Symptoms  Initials  Follow up  t  p 
Mean ± S.D.  Mean ± S.D. 
1  Nervousness  2.35 ± 0.926  1.88 ± 0.597  4.542        0.001 
2  Palpitation  1.91 ± 0.659  0.66 ± 0.472  3.364        0.001 
3  Tremors  1.56 ± 0.957  0.50 ± 0.763  2.829        0.01 
4  Headache  1.66 ±0.760  0.78 ± 0.593  3.533        0.01 
5  Anorexia  2.08 ± 0.650  0.60 ± 0.630  5.440        0.01 
6  Insomnia  1.66 ± 0.641  0.50 ± 0.763  5.272        0.001 
7  Lack of 
concentration 
2.08 ± 0.961   0.75 ± 0.721  6.385        0.001 
8  Dyspepsia / 
Flatulence 
2.00 ± 1.080  6.66 ± 0.480  3.927        0.001 
 
9  Fatigue / 
Exhaustion  
2.25 ± 0.325  0.21 ± 0.649  6.870        0.001 
 
10  Irritability  2.33 ± 1.704  0.83 ± 0.557  2.900        0.01 
 
 
Values are Mean Grade Scores ± S.D. Difference compared wit respective initial values 
 
TABLE –V 
Showing the pattern of reduction in Depression Index in cases of Anxiety Neurosis after 
treatment with Medhya Rasayana 
Observation  Initial value  Follow up-I  
(20 cases) 
t  p 
Mean ± S.D.  Mean ± S.D. 
Depression Index  9.58 ± 2.81 (19)  6.57± 2.60 (19)  3.424        0.01 
 
Observation  Initial value  Follow up-I  
(20 cases) 
t  p 
Mean ± S.D.  Mean ± S.D. 
Depression Index  10.00 ± 2.73 (8)  5.00± 2.78 (8)  3.626        0.01 
 
Values are Mean Raw Scores. 
Number of observations within paranthesis 
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Have selected Anxiety Neurosis as the 
subject of study.  Thus it is essential to point 
out at the outset that the present study does 
not encompass the total spectrum of Manas 
Roga and relates only to an important aspect 
of the diathesis of mental illness. 
It may further be clarified that Medhya 
Rasayana therapy in the present context 
refers to a combined treatment with the four 
classical Medhya Rasayana described in 
caraka samhita namely Sankhapuspi, 
Mandukaparni, Guduci and Yastimadhu. 
The role of these drug has already been 
evaluated individually for their anti-anxiety 
effect earlier by other workers in our group.  
The object of the present study is to evaluate 
the role of the combined use of these four 
Medhya Rasayana drugs in Anxiety 
Neurosis. 
Most of the compound and single drugs 
described for the treatment of mental 
diseases consists of Medhya and Rasayana 
drug of herbomineral origin.  Among the 
drugs which are advocated with priority for 
the treatment of mental disease, the Medhya 
Rasayanas a eth most important ones.  It is 
in view of their uses mentioned in 
Ayurvedic classics as well as their prevalent 
use, that we selected these drugs for their 
evaluation in the management of mental 
diseases. 
The beneficial effects of Medhya Rasayana 
therapy in the present series of patients 
appears to be due to the possible anti- 
anxiety activities of Medhya Rasayana drugs 
especially Sankhapuspi and Mandukoparni, 
besides the general Rasayana and 
adaptogenic  effects of these drugs. The 
remaining two drugs namely Guduci and 
Yastimadhu may not necessarily possess 
psychotropic action, but they appear to 
contribute adjuvant effects through other 
restorative attributes.  The Medhya rasayana 
could develop varying degree of resistance 
against stress and could adopt well with 
stressful situation. 
In view of the contributory activities of the 
Four Medhya Rasayana drugs including 
antianxiety, anti-depressant, adaptogenic 
and restorative effective effects it appears 
useful to combine these drugs in form of a 
compound Rasayana with predominant 
Medhya effect. This combination appears to 
be further benefitted by the healing 
properties of Yastimadhu and the bitter tonic 
effect of Guduci besides their general 
Rasayana and restorative effects. 
Madhuyasti being a mild laxative specially 
suits the patient of different type of Manas 
Roga because most of these patients are 
constipated and measure affording laxation 
and Vatanulomana always produce 
beneficial effects.  As also observed by 
some of our colleagues, a regular mild 
Virecana therapy is an useful adjuvant in the 
care of mental patients. 
Thus there are many benefits of combing 
four Medhya Rasayana drugs to develop a 
routine treatment for all forms of mental 
illness.  The Medhya rasayana Kasaya use in 
the present trial is a simple cheap an safe 
remedy or all kinds of minor mental 
diseases.  These drugs may be helpful even 
in major mental diseases if used in higher 
doses.  However, it could be a best treatment 
as a maintenance therapy for mental patients 
including the patients of residual psychosis.  Page 11-16 
The present trial has shown no undesirable 
side effects in this drug and the treatment 
appears fairly safe and moderately effective.  
It is not possible to comment at this stage on 
the problem of addiction of these drugs 
because ours is only on a short term trial and 
we have not studied their withdrawal effects.  
Moreover, in view of the moderate activity 
and the general adaptogenic restorative 
effects the chances of addiction are minor.  
Thus the present study undertaken for 
clinical evaluation of Medhya  rasayana 
therapy in Manas Roga has yielded evidence 
to suggest that the combined Medhya 
rasayana therapy is safe and moderately 
effective remedy for the care of a wide range 
of minor and moderate mental illhealth 
problem. 
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